OverviewSuggest Edit

Predictive Oncology (formerly Precision Therapeutics and Skyline Medical) is a medical device company. It provides an environmentally conscientious system for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. The company offers the STREAMWAY Fluid Waste Management System that suctions surgical waste fluid from the patient using standard surgical tubing. 

TypePublic
Founded2002
HQEagan, MN, US
Websitepredictive-oncology.com

Latest Updates

Employees (est.) (Dec 2018)24(+42%)
Revenue (FY, 2020)$1.3 M(-11%)
Share Price (Dec 2021)$1(-1%)
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Predictive Oncology

Carl Schwartz

Carl Schwartz

Interim President and Cheif Executive Officer, Director
David Johnson

David Johnson

COO
Bob Myers

Bob Myers

CFO
David Dauwalter

David Dauwalter

Director of Product Management
Rodney Schmidt

Rodney Schmidt

Senior Design Engineer
Show more

Predictive Oncology Office Locations

Predictive Oncology has an office in Eagan
Eagan, MN, US (HQ)
2915 Commers Dr #900
Show all (1)

Predictive Oncology Financials and Metrics

Predictive Oncology Revenue

Embed Graph
View revenue for all periods
Predictive Oncology's revenue was reported to be $1.25 m in FY, 2020
USD

Revenue (Q1, 2021)

280.3k

Gross profit (Q1, 2021)

182.6k

Gross profit margin (Q1, 2021), %

65.1%

Net income (Q1, 2021)

(3.9m)

EBIT (Q1, 2021)

(3.8m)

Market capitalization (31-Dec-2021)

63.6m

Closing stock price (31-Dec-2021)

1.0

Cash (31-Mar-2021)

27.3m

EV

37.6m
Predictive Oncology's current market capitalization is $63.6 m.
USDQ2, 2011

Debt/Equity

-0.3 x

Debt/Assets

2.6 x

Financial Leverage

-0.1 x
Show all financial metrics

Predictive Oncology Acquisitions / Subsidiaries

Company NameDateDeal Size
CytoBioscienceAugust 01, 2017

Predictive Oncology Cybersecurity Score

Cybersecurity ratingPremium dataset

B

84/100

SecurityScorecard logo

Predictive Oncology Online and Social Media Presence

Embed Graph

Predictive Oncology News and Updates

Predictive Oncology – Year-end Shareholder Update!

EAGAN, Minn., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology, (POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to develop personalized cancer therapies, is moving in the right direction.

Pamela Bush, Ph.D., MBA, Joins Predictive Oncology as SVP of Strategic Sales and Business Development

Bush to lead Predictive Oncology’s novel sales effort towards cancer research technologies Bush to lead Predictive Oncology’s novel sales effort towards cancer research technologies

Predictive Oncology Acquires zPREDICTA, Inc.

zPREDICTA has developed a patented tumor-specific 3D cell culture platform that is complementary to Predictive Oncology’s Artificial Intelligence (AI) platform developed by Helomics. zPREDICTA’s uniquely designed 3D culture systems create a tumor microenvironment that is closer to the patient’s actu…

Predictive Oncology Launches Website Highlighting AI-Powered Cancer Research Advancements

Predictive Oncology is leveraging AI to streamline drug discovery and development, improve outcomes in clinical testing and forge a new frontier of cancer research Predictive Oncology is leveraging AI to streamline drug discovery and development, improve outcomes in clinical testing and forge a new …

Predictive Oncology Adjourns Special Meeting of Stockholders

MINNEAPOLIS, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced today that the Company’s Special Meeting of Stockholders, which was convened at 3:…

Predictive Oncology subsidiary, Helomics uses data from the 100,000 Genomes Project to better predict ovarian cancer outcomes

Initial results demonstrate that AI models of genomic data can predict cancer outcomes. This has the potential to help personalize ovarian cancer treatments and drive the discovery of new therapies. Initial results demonstrate that AI models of genomic data can predict cancer outcomes. This has the …
Show more

Predictive Oncology Blogs

Improving Vaccine and Drug Effectiveness with Artificial Intelligence

In the wake of the COVID-19 pandemic, vaccines and, perhaps more importantly, their effectiveness, has been on virtually everyone’s minds. Amidst the public discourse over the COVID-19 vaccine, though, much of the science around the medical efficacy of these pharmaceutical products have been lost. D…

Predictive Oncology Adjourns Annual Meeting of Stockholders to December 30, 2021

Predictive Oncology Adjourns Annual Meeting of Stockholders to December 30, 2021 Content Import Mon, 12/27/2021 - 17:10 Predictive Oncology Adjourns Annual Meeting of Stockholders to December 30, 2021 Dec 27, 2021 This release is a backfill from a News Wire …

How to Develop More Effective Cancer Treatments

It’s never been a chip shot developing cancer treatments. In fact, only 7.78% of all cancer drugs that enter phase 1 clinical trials are ultimately approved by the U.S. Food and Drug Administration (FDA), according to the Pharmaceutical Manufacturers Association. Of the 1,481 cancer drugs selected f…

A Crystal Clear Perspective on Drug Discovery: How Larry DeLucas is Improving Medications in the Fight Against Cancer

Dr. Larry DeLucas leads with what he’s most excited about — protein crystallography — casually neglecting to mention the fact that he’s been to outer space. “My expertise is protein crystallography; I determine the structure of proteins,” DeLucas said. “From that, you can design small molecule drugs…

From Catching Serial Killers to Mapping Tumors: How Richard Gabriel is Advancing Genetics Research

Richard Gabriel didn’t expect to work in cancer research, but now, after 30 years studying one of the most complex diseases known to humankind, the Senior Vice President of Research and Development for Predictive Oncology explains his work as if he were born to do it. “All the cells in our body like…

Predictive Oncology acquires zPREDICTA, Inc.

Predictive Oncology Acquires zPREDICTA, Inc.   zPREDICTA has developed a patented tumor-specific 3D cell culture platform that is complementary to Predictive Oncology’s Artificial Intelligence (AI) platform developed by Helomics. zPREDICTA’s uniquely designed 3D culture systems create a tumor microe…
Show more

Predictive Oncology Frequently Asked Questions

  • When was Predictive Oncology founded?

    Predictive Oncology was founded in 2002.

  • Who are Predictive Oncology key executives?

    Predictive Oncology's key executives are Carl Schwartz, David Johnson and Bob Myers.

  • How many employees does Predictive Oncology have?

    Predictive Oncology has 24 employees.

  • What is Predictive Oncology revenue?

    Latest Predictive Oncology annual revenue is $1.3 m.

  • What is Predictive Oncology revenue per employee?

    Latest Predictive Oncology revenue per employee is $52.2 k.

  • Who are Predictive Oncology competitors?

    Competitors of Predictive Oncology include 19Labs, Trimedyne and VytronUS.

  • Where is Predictive Oncology headquarters?

    Predictive Oncology headquarters is located at 2915 Commers Dr #900, Eagan.

  • Where are Predictive Oncology offices?

    Predictive Oncology has an office in Eagan.

  • How many offices does Predictive Oncology have?

    Predictive Oncology has 1 office.